Press Releases Isofol Medical AB

Equities

ISOFOL

SE0009581051

Delayed Nasdaq Stockholm Other stock markets 09:08:31 2024-04-29 am EDT			5-day change	1st Jan Change
0.747 ^SEK	+7.64%		+3.89%	+2.33%

Feb. 20	Isofol Medical AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
Feb. 20	Isofol Medical AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Isofol Medical AB (publ) publishes annual report and corporate governance report for 2023	Apr. 16	AQ
Notice to attend the Annual General Meeting held on May 8, 2024 in Isofol Medical AB (publ)	Apr. 05	AQ
Isofol Medical : Japanese partner Solasia intensifies its commitment to the clinical development of arfolitixorin	Mar. 19	PU
Isofol’s Japanese partner Solasia intensifies its commitment to the clinical development of arfolitixorin	Mar. 19	AQ
Isofol presents a clinical development plan for arfolitixorin	Mar. 19	AQ
Isofol Medical : invites to investor meeting on March 19	Mar. 01	PU
Isofol Medical AB (publ) publishes year-end report, January - December 2023	Feb. 20	AQ
Isofol's Board of Directors decides to initiate the planning of clinical studies and will announce a strategic development plan on March 19	Feb. 14	AQ
Isofol appoints Magnus Hurst as new Chief Financial Officer	Jan. 10	AQ
Isofol appoints Petter Segelman Lindqvist as new CEO	Jan. 09	AQ
Bulletin from extraordinary general meeting in Isofol Medical AB (publ) held on January 4, 2024	Jan. 04	AQ
Isofol presents additional results from laboratory tests with arfolitixorin showing supplementary effects	Dec. 28	AQ
Isofol's board of directors announces its position on minority shareholder's proposal ahead of extraordinary general meeting	Dec. 13	AQ
Isofol has received the first results from laboratory tests of arfolitixorin	Dec. 07	AQ
Isofol is liquidating a subsidiary	Dec. 01	AQ
Notice convening the Extraordinary General Meeting in Isofol Medical AB (publ) 4 January 2024	Nov. 21	AQ
Isofol Medical AB (publ) publishes interim report, January-September 2023	Nov. 10	AQ
Isofol has obtained a request to call an extraordinary general meeting	Nov. 09	AQ
Isofol appoints nomination committee ahead of the Annual General Meeting 2024	Nov. 08	AQ
Isofol Medical AB (publ) has taken note of the results from the Modelle 001 study	23-10-05	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Isofol Medical AB

Equities

ISOFOL

SE0009581051

Press Releases

Filters